This article is part of a Chronicle. See more from this Chronicle
George Addy, Erika Douglas, Mar 26, 2014
The Canadian Competition Bureau has been signaling a renewed interest in competition enforcement in the pharmaceuticals industry, and more broadly, issues at the forefront of intellectual property and competition law. While enforcement in this space has seen significant attention from other major antitrust regulators, this marks a shift for the Bureau. Most significantly, the Bureau has com
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.224.32.86
Please verify email or join us to access premium content!